Mina Kodaira
Nippon Medical School
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mina Kodaira.
Bone | 2003
Hironori Iwasaki; Mitsuru Emi; Yoichi Ezura; Ryota Ishida; Mitsuko Kajita; Mina Kodaira; Hideyo Yoshida; Takao Suzuki; Takayuki Hosoi; Satoshi Inoue; Masataka Shiraki; Jeff Swensen; Hajime Orimo
Osteoporosis is believed to result from interplay among multiple environmental and genetic determinants, including factors that regulate bone mineral density (BMD). Among those factors, adequate estrogen is essential for achievement of peak bone mass as well as for postmenopausal maintenance of skeletal homeostasis. Gonadotropin-releasing hormone (GnRH) from the hypothalamus is the primary determinant in the hypothalamic-pituitary-gonadal feedback system. In genetic studies of 384 postmenopausal Japanese women, we found a significant association between BMD and an amino acid variation (Trp16Ser) located within the signal peptide of GnRH (r = 0.143, P = 0.005). These results were achieved by genotyping all subjects using a newly developed SNP-dependent PCR method. This automated, high-throughput, and inexpensive procedure is suitable for typing large numbers of samples. BMD was lowest among 16Ser/Ser homozygotes, highest among 16Trp/Trp homozygotes, and intermediate among heterozygotes. A case-control study involving 125 osteoporosis patients and 92 healthy controls revealed a significant association between the presence of a 16Ser GnRH allele and affected status (chi(2) = 4.74, P = 0.041). The results suggested that variation of the GnRH signal peptide may be an important risk factor for postmenopausal osteoporosis.
Journal of Human Genetics | 2001
Hironori Iwasaki; Yasutomo Shinohara; Yoichi Ezura; Ryota Ishida; Mina Kodaira; Mitsuko Kajita; Toshiaki Nakajima; Tadayoshi Shiba; Mitsuru Emi
AbstractOsteopontin (OPN) is one of the major noncollagenous bone matrix proteins produced by osteoblasts and osteoclasts. We systematically surveyed the entire structure of the OPN gene for single-nucleotide polymorphisms (SNPs) by directly sequencing 48 alleles derived from 24 unrelated Japanese individuals. We identified 13 SNPs in the OPN gene. Ten polymorphisms were identified in introns 1, 3, and 5; 2 in the coding region of exons 6 and 7; and 1 in the 3′ untranslated region of exon 7. Allele frequencies for some of the polymorphisms were significantly different from those reported in the United States National Center for Biotechnology Information (NCBI) dbSNP database. These polymorphisms will be useful in genetic studies to evaluate the role of OPN proteins in bone metabolism.
Journal of Human Genetics | 2003
Mitsuko Kajita; Yoichi Ezura; Hironori Iwasaki; Ryota Ishida; Hideyo Yoshida; Mina Kodaira; Takao Suzuki; Takayuki Hosoi; Satoshi Inoue; Masataka Shiraki; Hajime Orimo; Mitsuru Emi
AbstractOsteoporosis is believed to result from interplay among multiple environmental and genetic determinants, including factors that regulate bone-mineral density (BMD). Recent quantitative trait locus analysis in human suggested a possible involvement of chromosomal region 1p36.2−p36.3 for determination of BMD. The brain natriuretic peptide (BNP, also named NPPB) gene lies within this candidate region for BMD determination. Overexpression of the BNP resulted in skeletal overgrowth in transgenic mice. Association analysis between nucleotide variations of the BNP gene and radial BMD in 378 Japanese postmenopausal women revealed a significant association of the −381T/C variation of the BNP gene with radial BMD (r = 0.17, P = 0.01). Homozygous T-allele carriers had the lowest BMD values (0.395 ± 0.056g/cm2), homozygous C-allele carriers had the highest (0.429 ± 0.051g/cm2), and heterozygous individuals had intermediate radial BMD values (0.405 ± 0.048g/cm2), indicating a dosage effect. Accelerated bone loss also correlated with the −381 T allele in a 5-year follow-up study (r = 0.21, P = 0.017). These results suggest that variation of BNP may be an important determinant of postmenopausal osteoporosis, in part through the mechanism of accelerated postmenopausal bone loss.
Journal of Human Genetics | 2001
Yasutomo Shinohara; Yoichi Ezura; Hironori Iwasaki; Ichirou Nakazawa; Ryouta Ishida; Mina Kodaira; Mitsuko Kajita; Tadayoshi Shiba; Mitsuru Emi
AbstractInterleukin 11 (IL11) is a member of the interleukin 6 (IL6)-related cytokine subfamily, which stimulates T cell-dependent development of immunoglobulin-producing B cells. IL11 is also an important paracrine regulator of bone metabolism that induces formation of osteoclasts. In the work reported here, we sequenced the entire IL11 structural gene of 48 alleles in a Japanese test population. These experiments identified ten single-nucleotide polymorphisms (SNPs) and determined their allelic frequencies. One polymorphism was identified upstream of exon 1, one in exon 3, four in intron 4 and four in the 3′ untranslated region (3′UTR) of exon 5. Based on the genotype data, we constructed six haplotypes in the tested population. Two-way comparisons of SNPs revealed two combinations in complete linkage disequilibrium, one with SNPs at nucleotide positions 2753, 3644, 5154, and 5568, and another with SNPs at positions 3686, 5141, and 5734. These results will be useful in disease-association studies where a contribution of the human IL11 gene has been suspected, especially in disorders affecting immune response and bone metabolism.
Journal of Human Genetics | 2001
Hironori Iwasaki; Nobutaka Ota; Toshiaki Nakajima; Yasutomo Shinohara; Mina Kodaira; Mitsuko Kajita; Mitsuru Emi
AbstractInterferon gamma (IFNG) plays important roles in the regulation of bone remodelling. We describe here six single-nucleotide polymorphisms (SNPs) in the IFNG gene, five of which are novel, and their allelic frequencies in the Japanese population, as determined by sequencing 48 alleles of the entire gene. Four of these polymorphisms were identified inside the third intron, at nucleotide (nt) positions 2459 (A/G), 2671 (T/C), 3177 (T/G), and 3273 (G/A). In exon 4, SNPs were identified at nt positions 5199 (A/T) and 5272 (A/G). These polymorphic sites will be useful for genetic studies of disorders that affect the inflammatory process or calcium metabolism.
Journal of Human Genetics | 2001
Ryota Ishida; Yoichi Ezura; Hironori Iwasaki; Ichiro Nakazawa; Mitsuko Kajita; Mina Kodaira; Hiromoto Ito; Mitsuru Emi
AbstractLeukemia inhibitory factor (LIF) is a pleiotropic cytokine implicated in various pathological conditions, such as rheumatoid arthritis and osteoporosis. Despite the possible importance of LIF as a therapeutic target, little is known about the bioregulation of the human LIF gene. We here sequenced the entire structure of the LIF gene of 48 alleles in the Japanese population. These experiments identified four single-nucleotide polymorphisms (SNPs) and determined their allelic frequencies from a 48-allele sequence in the Japanese population. All four SNPs found in the LIF gene were located within exon 3, that is, a C/T at nucleotide (nt) position 3951, a C/G at nt position 4376, an A/C at nt position 4442, and a G/A at nt position 5961 (nucleotide numbering starts from the ATG start codon). Based on the genotypic data, we constructed four major haplotypes in the tested population. Two-way comparisons of SNPs revealed complete linkage disequilibrium between SNPs at positions 3951, 4376, and 4442. These results may prove to be useful as genetic markers for population-based disease-association studies in osteoporosis.
Journal of Human Genetics | 2001
Mitsuko Kajita; Hironori Iwasaki; Nobutaka Ota; Yasutomo Shinohara; Mina Kodaira; Toshiaki Nakajima; Mitsuru Emi
AbstractWe describe three single nucleotide polymorphisms (SNPs) of the human colony-stimulating factor 2 (CSF2) gene and their allelic frequencies, as determined by direct sequencing of 48 alleles of the entire CSF2 gene. Three polymorphisms were identified, at nucleotide positions 1816 (T/C), 2284 (C/T), and 3079 (G/A). These polymorphisms will be useful in genetic studies not only of hematologic disorders but also of disorders of bone metabolism.
Annals of Human Biology | 2002
Yasutomo Shinohara; Yoichi Ezura; Hironori Iwasaki; Ichirou Nakazawa; Ryota Ishida; Toshiaki Nakajima; Mina Kodaira; Mitsuko Kajita; Tadayoshi Shiba; Mitsuru Emi
Background : Tumour necrosis factor-alpha (TNF f ) is an essential regulator of immune responses and is implicated to relate to several types of disease susceptibilities. Population information on polymorphisms is essential for the study of genetic diseases. Aim : To obtain accurate information about single nucleotide polymorphisms (SNPs) in the TNF f gene in the Japanese population. Subjects and Methods : The entire TNF f gene was screened for SNPs by directly sequencing 48 chromosomes derived from 24 unrelated Japanese individuals. Allele frequencies of each polymorphism were determined and compared with those previously reported in other populations. Results : Three SNPs, -308G/A at nt -308, IVS1 + 125G/A at nt 492 and IVS3 + 104G/A at nt 1359 were observed, of which one (IVS3 + 104G/A at nt 1359) was novel. In addition, allele frequencies of -308G/A were remarkably different from those presented in the NCBI dbSNP, indicating a significant ethnic difference. Conclusions : The polymorphisms and allele frequencies obtained in this study will be useful for genetic studies of common diseases such as osteoporosis and rheumatoid arthritis in the Japanese population.
Journal of Human Genetics | 2003
Fumihiro Omasu; Yoichi Ezura; Mitsuko Kajita; Ryota Ishida; Mina Kodaira; Hideo Yoshida; Takao Suzuki; Takayuki Hosoi; Satoshi Inoue; Masataka Shiraki; Hajime Orimo; Mitsuru Emi
DNA Research | 2002
Hironori Iwasaki; Yoichi Ezura; Ryota Ishida; Mitsuko Kajita; Mina Kodaira; Jim Knight; Steve Daniel; Michael Shi; Mitsuru Emi